CoChat

Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Background. Speech changes occur in the early stages of Parkinson’s disease (PD) and cause communication difficulties, leading to social isolation. Lee Silverman voice treatment (LSVT) is a speech therapy approach designed to improve patients’ language and voice capabilities. Objective. The effectiveness of the LSVT was compared with that of other speech interventions or no treatment to evaluate PD patients with dysarthria. Design. Systematic review with meta-analysis of randomized trials. Data Sources: PubMed, Embase, Cochrane Library, CNKI, and SinoMed library were searched from inception to December 2021 related to PD and LSVT. Method. Abstracts were screened and reviewed against the eligibility criteria (intervention group participants were PD assessed based on LSVT (LSVT Loud) and randomized control). Result. Ten randomized controlled trials were identified on speech symptoms in patients with PD. Compared with the respiratory therapy (RET) exercise, or no training group, a significant improvement was detected in the sound press level (SPL) after immediate treatment during the reading of vowel and rainbow passages and an increase in semitone standard deviation (STSD). Furthermore, the LSVT training significantly increased the participants’ scores on unified Parkinson’s disease rating scale (UPDRS-III) and speech intelligibility. Conclusion. This meta-analysis demonstrated the efficacy of LSVT in increasing vocal loudness and functional communication among individuals with PD. However, most studies included participants with mild-moderate PD. Thus, additional randomized controlled trials (RCTs) with large sample sizes are needed to validate the efficacy of LSVT in patients with different progressions of PD, including severe PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2021/3366870

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart displaying study selection.
Figure 1 Flowchart displaying study selection.CC BY · PubMed Central
Figure 2 Risk-of-bias summary: a review of authors' judgments about each risk-of-bias item for each included study.
Figure 2 Risk-of-bias summary: a review of authors' judgments about each risk-of-bias item for each included study.CC BY · PubMed Central
Figure 3 Risk-of-bias graph: a review of authors' judgments about each risk-of-bias item presented as percentages across all included studies.
Figure 3 Risk-of-bias graph: a review of authors' judgments about each risk-of-bias item presented as percentages across all included studies.CC BY · PubMed Central
Figure 4 SPL immediately after the treatment during a reading of vowel, rainbow passage, and monologues.
Figure 4 SPL immediately after the treatment during a reading of vowel, rainbow passage, and monologues.CC BY · PubMed Central
Figure 5 Forest plot showing mean difference and 95% CI of SPL at different assessment times. (a) 1–6 months. (b) 6–12 months.
Figure 5 Forest plot showing mean difference and 95% CI of SPL at different assessment times. (a) 1–6 months. (b) 6–12 months.CC BY · PubMed Central
Figure 6 VHI after immediate treatment.
Figure 6 VHI after immediate treatment.CC BY · PubMed Central
Figure 7 Forest plot showing mean difference and 95% CI of STSD during rainbow passage (a) and monologues (b).
Figure 7 Forest plot showing mean difference and 95% CI of STSD during rainbow passage (a) and monologues (b).CC BY · PubMed Central
Figure 8 Forest plot showing mean difference and 95% CI of UPDRS-III speech item score after immediate treatment.
Figure 8 Forest plot showing mean difference and 95% CI of UPDRS-III speech item score after immediate treatment.CC BY · PubMed Central
Figure 9 Forest plot showing mean difference and 95% CI of speech intelligibility immediately treatment.
Figure 9 Forest plot showing mean difference and 95% CI of speech intelligibility immediately treatment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. H. Y. Tang, 2016, Effect of speech therapy with Lee Silverman voice treatment on speech function of Parkinson’s disease patients, Journal of Nursing (China), 23, 66
  2. W. Qi, 2020, Application effect of stepped speech rehabilitation nursing in patients with Parkinson’s disease, Journal of Anhui health vocational and Technical College, 19, 63
  3. Y. Meifang, 2017, Lee Silverman voice treatment can improve the speech and the life quality of patients with Parkinson’s disease, Chinese Journal of Physical Medicine Rehabilitation, 39, 43

Cited by

See all 83

Metadata

Authors
Pu, T., Huang, M., Kong, X., Wang, M., Chen, X., Feng, X., Wei, C., Weng, X., & Xu, F.
Affiliations
  • Chengdu Medical College (CN)
  • Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences (CN)
Corresponding author
  • Weng, Xiechuan
  • Xu, Fan
Venue
Parkinson's Disease
Publisher
Wiley
Published
2021-12-27
Volume
2021
Pages
1-10
ISSN
  • 2042-0080 (ISSN-L)
  • 2090-8083
OpenAlex
W4200055663
Cited by
50
References
32
Citations by year
2026: 5 · 2025: 21 · 2024: 16 · 2023: 3 · 2022: 5
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • Parkinson s Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Chengdu Medical College (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
  • Chengdu Science and Technology Bureau Focused on Research and Development Support Plan (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
  • Popular Scientific Research Project of Sichuan Health Commission (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
  • Sichuan Undergraduate Innovation and Startup Program Funding Support (CYZ19-33, 2019-YF09-00097-SN, 20PJ171, S201913705080)
Topics
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
Keywords
Lee Silverman Voice Treatment, dysarthria, speech therapy, vocal intensity, speech intelligibility, respiratory care, sound pressure level, UPDRS-III, functional communication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.